OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $116,000 | -71.1% | 11,584 | -59.1% | 0.00% | -75.0% |
| Q2 2021 | $401,000 | +568.3% | 28,300 | +86.8% | 0.00% | +100.0% |
| Q4 2018 | $60,000 | -96.2% | 15,146 | -91.1% | 0.00% | -98.7% |
| Q1 2017 | $1,575,000 | -17.8% | 169,628 | -25.9% | 0.16% | -36.3% |
| Q4 2016 | $1,916,000 | +1239.9% | 228,901 | +995.1% | 0.25% | +933.3% |
| Q3 2016 | $143,000 | +47.4% | 20,903 | +6.3% | 0.02% | +9.1% |
| Q2 2016 | $97,000 | – | 19,670 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |